Overview
Remedy Meds competes primarily on pricing structure rather than headline price. Its compounded GLP-1s are sold at flat rates that do not increase with dose — $299 per month for compounded semaglutide and $399 per month for compounded tirzepatide, according to independent reviews including U.S. News.
That flat structure is worth more than it appears. Most providers — including every manufacturer-direct channel — price by dose, so a patient who titrates from a starting dose to a maintenance dose can see their monthly cost double or triple. At Remedy Meds, the number you sign up at is the number you keep paying. Over a year of treatment, that predictability is often worth more than a lower entry price that escalates.
Remedy Meds also offers a microdose plan at $189 per month, a lower-dose protocol at a reduced price. Microdosing has become a genuine segment of this market, appealing to patients who want appetite modulation without full therapeutic dosing, or who cannot tolerate standard escalation. It is not the same treatment as standard-dose GLP-1 therapy and should not be expected to produce equivalent results.
For patients who want FDA-approved medication, Remedy Meds has made brand-name options available — Forbes Health reported figures of $1,299 for Ozempic and $1,399 for Zepbound according to a customer service representative. Those are effectively retail-equivalent prices, and patients wanting brand-name medication will do considerably better through manufacturer-direct self-pay channels. Remedy Meds also reports a very large member base, citing self-reported data from approximately 300,000 members on personalized treatment plans.
What Makes Remedy Meds Different
Flat Rate Genuinely Means Flat
Compounded semaglutide at $299 and tirzepatide at $399 per month do not change as you titrate up. Against dose-tiered competitors where a patient can move from $299 to $699 as they escalate, this predictability is the single most valuable thing Remedy Meds offers.
A Real Microdose Tier at $189
The $189 per month microdose plan is a distinct product, not a discount. It suits patients who want appetite modulation at lower doses, or who cannot tolerate standard titration. Understand that it is not equivalent to standard-dose therapy and results will differ accordingly.
Scale and Published Outcome Data
Remedy Meds cites self-reported results from approximately 300,000 members on personalized treatment plans. Self-reported data has real limitations, but a member base of that size represents meaningful operational maturity relative to newer entrants.
Brand-Name Available, Though Not Competitively Priced
Brand-name options exist for patients who want FDA-approved product. We flag honestly that the reported figures of $1,299 for Ozempic and $1,399 for Zepbound are near retail — manufacturer-direct channels are dramatically cheaper for brand-name medication.
✓ Pros
- •Flat-rate pricing – cost does not increase as you titrate up
- •Budget predictability – the price you sign up at is the price you keep
- •Microdose plan at $189/month – a genuine lower-cost tier
- •Both molecules available – semaglutide and tirzepatide
- •Large member base – approximately 300,000 members per company data
- •Operational maturity – established fulfillment at scale
- •Brand-name available if wanted – though not competitively priced
- •Personalized treatment plans – dosing tailored rather than fixed protocol
✗ Cons
- •Entry price above market floor – $299 starting versus $99–$199 elsewhere
- •Tirzepatide at $399/month – expensive within the compounded segment
- •Brand-name pricing is near retail – $1,299 Ozempic, $1,399 Zepbound per Forbes reporting
- •Compounded regulatory position has narrowed – since GLP-1s left the FDA shortage list
- •Outcome data is self-reported – not independently verified
- •Microdosing is not equivalent therapy – expectations need calibrating
- •No insurance pathway for compounded medication – cash-pay only
Our #1 Recommended Provider
Remedy Meds’ flat-rate structure is genuinely valuable. If you want that same predictability at a substantially lower price point, Coreage RX remains our top recommendation.
Medications Offered
Brand-Name or Compounded?
Primarily compounded, with brand-name available. Remedy Meds’ core offering is flat-rate compounded semaglutide and tirzepatide. Brand-name FDA-approved options have been made available on request at prices reported near retail. Because compounded GLP-1s occupy a narrower regulatory position since leaving the FDA shortage list, ask directly about pharmacy sourcing and licensure.
Compounded semaglutide
$299/month flat rateFlat-rate pricing that does not increase as you titrate to higher doses, per independent reviews including U.S. News. This predictability is Remedy Meds’ central value proposition.
Compounded tirzepatide
$399/month flat rateThe dual GIP/GLP-1 molecule, also at a flat rate regardless of dose. Notably more expensive than semaglutide and above several compounded competitors.
Microdose GLP-1 plan
$189/monthA lower-dose protocol at a reduced price. This is a different treatment approach rather than a discounted version of standard therapy — results should be expected to differ.
Ozempic (brand-name)
Reported at $1,299Forbes Health reported this figure according to a Remedy Meds customer service representative. This is near retail pricing; manufacturer-direct self-pay channels are dramatically cheaper for brand-name semaglutide.
Zepbound (brand-name)
Reported at $1,399Forbes Health reported this figure according to a Remedy Meds customer service representative. LillyDirect’s published self-pay vial pricing is a fraction of this — see our LillyDirect review before buying brand-name here.
The compounded flat-rate pricing is Remedy Meds’ genuine strength. The brand-name pricing is not competitive and we would not recommend using Remedy Meds as a route to brand-name medication when manufacturer-direct channels publish far lower self-pay prices. Confirm current pricing directly before enrolling.
Pricing, Membership & Medication Fees
| Cost Item | What You Pay |
|---|---|
| Compounded semaglutide | $299/month flat — does not increase with dose |
| Compounded tirzepatide | $399/month flat — does not increase with dose |
| Microdose GLP-1 plan | $189/month |
| Ozempic (brand-name) | Reported at $1,299 per Forbes Health |
| Zepbound (brand-name) | Reported at $1,399 per Forbes Health |
| Dose escalation cost | None on compounded plans — this is the core benefit |
| Insurance | Compounded medication is a cash-pay pathway |
Compare Remedy Meds against dose-tiered providers over a full year at maintenance dose, not at the starting dose. A competitor advertising $299 at 2.5 mg but charging $699 at 10 mg costs considerably more over twelve months than Remedy Meds’ flat $299 — even though the headline numbers look identical.
How Remedy Meds Works
Complete the Online Intake
You provide medical history, current medications, weight history, and treatment goals. Remedy Meds describes personalized treatment plans rather than a single fixed protocol.
Choose Your Plan Tier
Standard compounded semaglutide at $299 flat, compounded tirzepatide at $399 flat, or the microdose plan at $189. Understand that microdosing is a different treatment approach with different expected outcomes, not a cheaper version of the same thing.
Clinician Review and Prescription
A licensed clinician reviews your intake and determines whether the selected medication and dosing approach is appropriate for you.
Confirm the Flat Rate Applies to Your Full Titration
Flat-rate pricing is the reason to choose Remedy Meds, so confirm in writing that your quoted rate holds at every dose level through your expected maintenance dose.
Medication Shipment
Compounded medication ships from a compounding pharmacy. Injectable GLP-1s are temperature-sensitive and should go into refrigeration promptly on arrival.
Ongoing Titration and Support
Dose escalation happens under clinician guidance without a price change on compounded plans. Contact your clinician promptly if gastrointestinal symptoms are severe rather than pushing through them.
Program Details at a Glance
| Detail | Remedy Meds |
|---|---|
| Consultation process | Online intake followed by licensed clinician review, included in the plan price. |
| Eligibility | Adults meeting clinical criteria for GLP-1 therapy, as determined by the reviewing clinician. |
| Provider involvement | Licensed clinicians review, prescribe, and guide titration. Remedy Meds describes personalized treatment plans. |
| Lab requirements | May be requested based on clinical history. Confirm requirements for your plan. |
| Pharmacy fulfillment | Compounding pharmacies dispense the semaglutide and tirzepatide preparations. Ask Remedy Meds directly which pharmacy and under what licensure. |
| Shipping frequency | Monthly shipments. Injectables require cold-chain handling and refrigeration on arrival. |
| Support services | Clinician access for titration and side-effect management as part of the plan. |
| Membership fee | Pricing is presented as flat monthly plan rates rather than a separate membership plus medication fee. |
| Medication fee | Compounded semaglutide $299/month flat; compounded tirzepatide $399/month flat; microdose plan $189/month. Brand-name reported at $1,299 (Ozempic) and $1,399 (Zepbound). |
| Cancellation policy | Confirm cancellation terms and notice requirements directly with Remedy Meds before enrolling. |
| Refund policy | Confirm the refund policy directly with Remedy Meds. Dispensed medication is generally non-returnable. |
| Insurance | Compounded medication is a cash-pay pathway. Brand-name options are sold at cash prices reported near retail. |
| HSA / FSA | Prescription and eligible medical costs are generally HSA/FSA eligible. Confirm with your plan administrator. |
| States served | Availability depends on clinician licensure in your state. Confirm before enrolling. |
Who Remedy Meds Is Best For
✓ Best For:
- • Patients who expect to titrate to high doses and want predictable cost
- • Anyone burned by dose-tiered pricing that escalated unexpectedly
- • Patients interested in a genuine microdose protocol at $189/month
- • People who value operational maturity and scale over the lowest price
- • Patients who want personalized dosing rather than a fixed protocol
- • Anyone comfortable with compounded medication’s current regulatory position
- • Patients budgeting a full year of treatment rather than a trial month
✗ Not Best For:
- • Cost-sensitive patients — $299 is well above the compounded market floor
- • Anyone buying brand-name medication, where the reported pricing is near retail
- • Patients who want tirzepatide affordably, at $399/month
- • People who want to bill treatment to insurance
- • Patients who need independently verified outcome data
- • Anyone who wants coaching or dietitian support included
Limitations to Know Before You Sign Up
- ⚠️The $299 entry price is well above the compounded market floor. Flat-rate predictability is genuinely valuable, but providers offering flat rates at $99 to $199 deliver the same benefit for less.
- ⚠️Compounded tirzepatide at $399 per month is expensive within the segment. If tirzepatide is your priority, compare specifically on that molecule.
- ⚠️Brand-name pricing reported at $1,299 for Ozempic and $1,399 for Zepbound is near retail. Manufacturer-direct self-pay channels publish dramatically lower prices — do not buy brand-name here without comparing.
- ⚠️Outcome claims are based on self-reported member data. Self-reported weight-loss data systematically overstates results and is not equivalent to clinical trial evidence.
- ⚠️Microdosing is a distinct treatment approach, not a discounted version of standard therapy. Expected results differ, and patients should understand that before choosing the $189 tier for cost reasons alone.
- ⚠️Compounded GLP-1s occupy a narrower regulatory position since leaving the FDA shortage list. Ask directly about pharmacy sourcing and licensure.
Alternatives to Remedy Meds
Coreage RX
Our top-rated provider offering the same flat-rate predictability at $99/month.
Mochi Health
Flat-rate compounded GLP-1s at all doses, with unlimited dietitian access included.
LillyDirect
If you want brand-name Zepbound, manufacturer-direct self-pay pricing is far below Remedy Meds’ reported figure.
Maximus
Another microdose-focused provider, at a lower starting price point.
Frequently Asked Questions
How much does Remedy Meds cost?
Independent reviews including U.S. News report flat-rate pricing of $299 per month for compounded semaglutide and $399 per month for compounded tirzepatide, with a microdose plan at $189 per month. Brand-name options have been reported at $1,299 for Ozempic and $1,399 for Zepbound.
What does flat-rate pricing actually mean?
Your monthly cost does not increase as you titrate to higher doses. Most competitors price by dose, so a patient escalating from a starting dose to a maintenance dose can see costs double or triple. At Remedy Meds, the compounded rate stays the same.
Is the $189 microdose plan the same medication?
It uses the same active ingredient at lower doses under a different protocol. It is a distinct treatment approach rather than a discounted version of standard therapy, and expected results differ. Do not choose it purely on price without understanding that.
Should I buy brand-name medication through Remedy Meds?
In our assessment, no. Reported prices of $1,299 for Ozempic and $1,399 for Zepbound are near retail. Manufacturer-direct channels such as LillyDirect and NovoCare Pharmacy publish self-pay prices that are a fraction of those figures.
Is Remedy Meds’ outcome data reliable?
Remedy Meds cites self-reported data from approximately 300,000 members. Self-reported weight-loss data systematically overstates results relative to measured outcomes and is not equivalent to clinical trial evidence. Treat it as directional rather than definitive.
Does Remedy Meds take insurance?
Compounded medication is a cash-pay pathway. Brand-name options are sold at cash prices.
Is $299 a good price for compounded semaglutide?
It is mid-to-high within the segment. Providers offering flat rates at $99 to $199 give you the same dose-escalation protection for considerably less. Remedy Meds’ argument is operational maturity and scale rather than price leadership.
Is compounded semaglutide the same as Wegovy?
No. It contains the same active ingredient but is not an FDA-approved product and is prepared by a compounding pharmacy. Since semaglutide left the FDA shortage list, the legal basis for routine compounding narrowed considerably.
The Bottom Line
Remedy Meds earns 4.0 out of 5 stars for solving a real problem that most of this market creates: dose-based price escalation. Flat rates of $299 for compounded semaglutide and $399 for tirzepatide mean the number you sign up at is the number you keep paying, even as you titrate to maintenance. For a patient budgeting a full year of treatment, that predictability is worth more than a lower entry price that triples by month six.
The microdose plan at $189 per month is also a legitimate product rather than a marketing tier, serving patients who want appetite modulation at lower doses or who cannot tolerate standard escalation. And with a member base the company puts at roughly 300,000, Remedy Meds has operational maturity that newer entrants lack.
Two things limit the score. The compounded entry price of $299 sits well above the market floor — providers offering flat rates at $99 to $199 deliver identical dose-escalation protection for a third of the cost, which makes Remedy Meds’ pricing argument hard to sustain on value alone. And the brand-name pricing reported at $1,299 for Ozempic and $1,399 for Zepbound is near retail, which we cannot recommend when manufacturer-direct self-pay channels publish far lower numbers.
Our recommendation: If you want flat-rate compounded pricing, Coreage RX at $99/month provides the same structural benefit at a third of the price. If you want brand-name medication, go to LillyDirect or NovoCare Pharmacy rather than paying near-retail here. Remedy Meds is a reasonable choice if scale and operational maturity outweigh price for you.
Disclosure:
This review is based on publicly available information from Remedy Meds’ own website plus independent reviews including U.S. News and Forbes Health, current as of August 24, 2026. Presidential GLP-1 may receive compensation from some providers featured on this site, which helps us provide free, independent reviews; we do not have a compensation relationship with Remedy Meds. Brand-name pricing figures were reported by Forbes Health according to a company customer service representative and may not reflect current pricing. Outcome claims are based on company self-reported member data, which is not independently verified. Compounded medications are not FDA-approved products and their regulatory position has narrowed since semaglutide and tirzepatide left the FDA shortage list. Verify current pricing directly with Remedy Meds before enrolling. We do not sell, dispense, or ship medication.
⚕️ Medical Disclaimer:
This review is for informational purposes only and is not medical advice, diagnosis, or treatment. GLP-1 receptor agonists are prescription medications with serious risks and contraindications, including a boxed warning for thyroid C-cell tumors. Only a licensed clinician who knows your medical history can determine whether any weight-management medication is appropriate for you. Never start, stop, or change a prescription based on this page. If you experience severe abdominal pain, persistent vomiting, signs of an allergic reaction, or other concerning symptoms, seek medical care immediately. See our full medical disclaimer.
Or check out our top-rated provider